Paper41997233
Loss of hepatocyte PI3Kα reduces hepatocellular carcinoma and hepatocyte proliferation in association with altered lipid metabolism.
Becattini B and 6 others. JHEP Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Loss of hepatocyte PI3Kα reduces hepatocellular carcinoma and hepatocyte proliferation in association with altered lipid metabolism. Papers, record 41997233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Loss of hepatocyte PI3Kα reduces hepatocellular carcinoma and hepatocyte proliferation in association with altered lipid metabolism.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatocytes | Major topic |
| Lipid Metabolism | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Animals | |
| Cell Proliferation | |
| Mice | |
| Mice, Knockout | |
| Diethylnitrosamine | |
| Diet, High-Fat | |
| Male | |
| Signal Transduction | |
| Proto-Oncogene Proteins c-akt |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30051890 | Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. | Nature | 2018 | https://conductscience.org/library/papers/30051890 | PubMed |
| 2 | 40228209 | Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling. | PLoS Biol | 2025 | https://conductscience.org/library/papers/40228209 | PubMed |
| 3 | 32764740 | Liver regeneration: biological and pathological mechanisms and implications. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/32764740 | PubMed |
| 4 | 32055031 | The nf-core framework for community-curated bioinformatics pipelines. | Nat Biotechnol | 2020 | https://conductscience.org/library/papers/32055031 | PubMed |
| 5 | 21464441 | Ablation of PI3K p110-α prevents high-fat diet-induced liver steatosis. | Diabetes | 2011 | https://conductscience.org/library/papers/21464441 | PubMed |
| 6 | 16452245 | Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats. | Cancer Res | 2006 | https://conductscience.org/library/papers/16452245 | PubMed |
| 7 | 26925227 | Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. | F1000Res | 2015 | https://conductscience.org/library/papers/26925227 | PubMed |
| 8 | 31645765 | Pan-cancer whole-genome analyses of metastatic solid tumours. | Nature | 2019 | https://conductscience.org/library/papers/31645765 | PubMed |
| 9 | 28398311 | Nextflow enables reproducible computational workflows. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/28398311 | PubMed |
| 10 | 15199412 | Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15199412 | PubMed |
| 11 | 30482855 | Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30482855 | PubMed |
| 12 | 28263959 | Salmon provides fast and bias-aware quantification of transcript expression. | Nat Methods | 2017 | https://conductscience.org/library/papers/28263959 | PubMed |
| 13 | 38861922 | An adipoincretin effect links adipostasis with insulin secretion. | Trends Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38861922 | PubMed |
| 14 | 30300952 | PI3Kδ Is a Therapeutic Target in Hepatocellular Carcinoma. | Hepatology | 2018 | https://conductscience.org/library/papers/30300952 | PubMed |
| 15 | 24910242 | Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. | Cell Metab | 2014 | https://conductscience.org/library/papers/24910242 | PubMed |
| 16 | 38656871 | Adipocyte PI3K links adipostasis with baseline insulin secretion at fasting through an adipoincretin effect. | Cell Rep | 2024 | https://conductscience.org/library/papers/38656871 | PubMed |
| 17 | 34748271 | RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues. | Mol Oncol | 2022 | https://conductscience.org/library/papers/34748271 | PubMed |
| 18 | 26996309 | Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. | Cancer Cell | 2016 | https://conductscience.org/library/papers/26996309 | PubMed |
| 19 | 30982732 | Insulin-Driven PI3K-AKT Signaling in the Hepatocyte Is Mediated by Redundant PI3Kα and PI3Kβ Activities and Is Promoted by RAS. | Cell Metab | 2019 | https://conductscience.org/library/papers/30982732 | PubMed |
| 20 | 32694512 | Insulin signaling and glucose metabolism in different hepatoma cell lines deviate from hepatocyte physiology toward a convergent aberrant phenotype. | Sci Rep | 2020 | https://conductscience.org/library/papers/32694512 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41997233
GET https://conductscience.org/api/papers/v1/41997233/references?page=2